SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

01 Feb 2022 Evaluate
A slight decline in the revenue of Rs. 2364.70 millions was seen for the December 2021 quarter as against Rs. 2453.92 millions during year-ago period.The Net Profit of the company slipped to Rs. 127.31 millions from Rs. 266.73 millions, a decline of -52.27% on QoQ basis.The company reported a degrowth in operating Profit to 341.94 millions from 467.05 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 2364.70 2453.92 -3.64 6952.05 6922.09 0.43 9369.13 7627.11 22.84
Other Income 19.00 1.95 874.36 42.43 14.98 183.24 160.95 38.86 314.18
PBIDT 341.94 467.05 -26.79 1049.27 1225.04 -14.35 1625.39 1053.44 54.29
Interest 33.22 44.39 -25.16 107.25 133.20 -19.48 178.98 215.71 -17.03
PBDT 308.72 422.66 -26.96 942.02 1091.84 -13.72 1446.41 837.73 72.66
Depreciation 127.75 104.07 22.75 365.85 285.37 28.20 396.79 312.76 26.87
PBT 180.97 318.59 -43.20 576.17 806.47 -28.56 1049.62 524.97 99.94
TAX 53.66 51.86 3.47 159.12 175.78 -9.48 246.67 366.16 -32.63
Deferred Tax 9.23 8.83 4.53 25.20 97.96 -74.28 121.84 366.16 -66.72
PAT 127.31 266.73 -52.27 417.05 630.69 -33.87 802.95 158.81 405.60
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 14.46 19.03 -24.02 15.09 17.70 -14.72 17.35 13.81 25.61

Neuland Laboratories Share Price

15936.35 937.65 (6.25%)
04-May-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.15
Dr. Reddys Lab 1297.65
Cipla 1322.15
Zydus Lifesciences 901.75
Lupin 2337.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×